285 related articles for article (PubMed ID: 34962448)
1. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
[TBL] [Abstract][Full Text] [Related]
2. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
[TBL] [Abstract][Full Text] [Related]
4. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma.
Huang X; Wu W; Yang W; Qing X; Shao Z
Colloids Surf B Biointerfaces; 2020 Jun; 190():110891. PubMed ID: 32114271
[TBL] [Abstract][Full Text] [Related]
7. Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy.
Zhong J; Wen W; Wang J; Zhang M; Jia Y; Ma X; Su YX; Wang Y; Lan X
Pharm Res; 2023 Jan; 40(1):231-243. PubMed ID: 36380167
[TBL] [Abstract][Full Text] [Related]
8. Nanocarrier-based drug delivery systems for bone cancer therapy: a review.
Prasad SR; Kumar TSS; Jayakrishnan A
Biomed Mater; 2021 May; 16(4):. PubMed ID: 33853043
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
Desai SA; Manjappa A; Khulbe P
J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
[TBL] [Abstract][Full Text] [Related]
10. Liposomal delivery of vascular endothelial growth factor/receptors and their inhibitors.
Khodabakhsh F; Muyldermans S; Behdani M; Kazemi-Lomedasht F
J Drug Target; 2020 Apr; 28(4):379-385. PubMed ID: 31822133
[TBL] [Abstract][Full Text] [Related]
11. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.
González-Fernández Y; Imbuluzqueta E; Patiño-García A; Blanco-Prieto MJ
Curr Pharm Des; 2015; 21(42):6104-24. PubMed ID: 26503148
[TBL] [Abstract][Full Text] [Related]
13. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
14. Advances in lipid-based nanocarriers for breast cancer metastasis treatment.
Joun I; Nixdorf S; Deng W
Front Med Technol; 2022; 4():893056. PubMed ID: 36062261
[TBL] [Abstract][Full Text] [Related]
15. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
16. Osteotropic therapy via targeted layer-by-layer nanoparticles.
Morton SW; Shah NJ; Quadir MA; Deng ZJ; Poon Z; Hammond PT
Adv Healthc Mater; 2014 Jun; 3(6):867-75. PubMed ID: 24124132
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach.
Santos A; Domingues C; Jarak I; Veiga F; Figueiras A
Eur J Pharm Biopharm; 2022 Jan; 170():91-111. PubMed ID: 34896571
[TBL] [Abstract][Full Text] [Related]
18. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
19. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
